Frequency, risk factors, and outcomes of central nervous system relapse in lymphoma patients treated with dose-adjusted EPOCH plus rituximab

Mary Kate Malecek, Adam M. Petrich, Shaina Rozell, Benjamin Chu, Steven Trifilio, Natalie Galanina, Matthew Maurer, Umar Farooq, Brian K. Link, Grzegorz S. Nowakowski, Chadi Nabhan, Ayed O. Ayed

Research output: Contribution to journalArticle

4 Scopus citations

Fingerprint Dive into the research topics of 'Frequency, risk factors, and outcomes of central nervous system relapse in lymphoma patients treated with dose-adjusted EPOCH plus rituximab'. Together they form a unique fingerprint.

Medicine & Life Sciences